Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €60.50 | €75.80 | 25.289% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €74.00 | €79.00 | 6.757% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.50 | €247.61 | 14.368% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €188.60 | - | - |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.29 | €2.78 | 115.783% |
| Cutera Inc. | 1 | 0 | 0 | 0 | €2.14 | €3.00 | 40.252% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.80 | €26.01 | 19.295% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €13.96 | - | - |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.40 | €26.58 | 8.940% |
| Corcept Therapeutics Inc. | 9 | 0 | 2 | 0 | €21.99 | €33.55 | 52.554% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €134.90 | €137.63 | 2.027% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €145.15 | €173.22 | 19.338% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €87.40 | - | - |
| Lemaitre Vascular Inc | 1 | 0 | 0 | 0 | €60.00 | - | - |
| ShockWave Medical Inc | 1 | 0 | 0 | 0 | €307.50 | - | - |
| Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €71.52 | €100.00 | 39.821% |
| SCYNEXIS Inc. | 5 | 0 | 2 | 0 | €1.73 | €3.00 | 73.611% |
| Immunogen Inc. | 7 | 0 | 1 | 0 | €28.97 | - | - |
| Baxter International | 3 | 0 | 0 | 0 | €37.49 | €48.16 | 28.481% |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.00 | €13.74 | 1271.477% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.77 | €8.50 | 25.554% |
| Tenet Healthcare | 23 | 0 | 2 | 0 | €95.00 | €95.79 | 0.836% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.67 | €55.00 | 4.424% |
| Vivoryon Therapeutics N.V. | 1 | 0 | 0 | 0 | €0.64 | - | - |